Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sonic Healthcare Limited ( (AU:SHL) ) has issued an update.
Sonic Healthcare Limited has announced a change in the director’s interest, specifically involving Christopher David Wilks. The notice details the director’s direct and indirect interests in the company’s securities, including ordinary shares and unlisted options. This update reflects the company’s ongoing commitment to transparency in its governance and may influence stakeholder perceptions regarding the company’s leadership and financial strategies.
The most recent analyst rating on (AU:SHL) stock is a Buy with a A$29.00 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, providing laboratory and radiology services. The company is known for its comprehensive diagnostic services and has a significant presence in the global market.
Average Trading Volume: 1,337,522
Technical Sentiment Signal: Sell
Current Market Cap: A$11.34B
For detailed information about SHL stock, go to TipRanks’ Stock Analysis page.